Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREArtificial intelligence is accelerating opportunities. Realizing the benefits for healthcare requires the right expertise. Together, we can solve the problems of today, and drive the breakthroughs of tomorrow.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREIQVIA enables genomic research via global access to a network of genomic-clinical data, proprietary technologies that enable federated analytics, and therapeutic area & bioinformatics expertise to help you answer your most pressing research questions.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSEstablished in the 1980s, IQVIA Malaysia has one of the most comprehensive offering portfolios in the region. We offer a full spectrum of clinical and commercial solutions for biopharmaceutical, medical device and other healthcare clients.
We have a strong history of innovation to meet client needs. Two of our 11 Prime Sites in Asia Pacific are in Malaysia. Prime Sites are major leading institutions with access to large numbers of patients and broad therapeutic expertise.
In 2014 we introduced the Malaysia Distributors Pharmaceutical Index (MDPI) to provide monthly market performance monitoring; in 2013 Malaysia MOH collaborated with our company to collate all the MOH Pharmaceutical procurement data, enabling IQVIA to launch the of Malaysia institute and Government Hospital Report (MiGHT).
Some of our other commercial solutions include the Malaysia Pharmaceutical Audit with postcode level data and the Malaysia Government Report, a consolidated view of the overall biopharmaceutical market.
Malaysia’s healthcare infrastructure continues to evolve. The government is promoting disease prevention and healthier living; it is improving healthcare access to address the rapidly growing incidence of chronic non-communicable diseases. Expansion of the private hospital sector, helped by liberalization of foreign investment and encouragement of medical tourism and the medical travel industry, presents further growth opportunity.
Government cost-containment measures include promotion of generics, the closer monitoring of drug prices, and changes to the pricing system, as well as a proposed pharmacoeconomic evaluation for listing on the Ministry of Health Formulary.
Supported by the world's largest and most diverse set of healthcare information with global breadth and granular depth of actionable insights, IQVIA Malaysia offers the following solutions:
IQVIA has two decades of clinical research experience in Malaysia. We have the resources, experience and site relationships necessary to help our clients' conduct clinical research in Malaysia to global standards. We have strong relationships with Malaysia's top hospitals and leading clinical research institutions. This enables faster study start-up and rapid patient recruitment. Our operations teams in Malaysia are seamlessly connected to our company's global infrastructure and leading experts across the global.
Our extensive experience enhances our ability to identify and resolve study issues before they become problems. This experience is especially important during start-up, when inexperience can cause costly delays. Our solid relationships with leading sites and investigators enable us to collect high-quality data quickly and conduct trials in Malaysia to global standards.